Emilio Bouza Santiago-rekin lankidetzan egindako argitalpenak (17)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

2022

  1. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

2021

  1. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  2. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

2020

  1. Colonization of the nasal airways by Staphylococcus aureus on admission to a major heart surgery operating room: A real-world experience

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 10, pp. 466-470

2008

  1. Bloodstream infections: Evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006

    Medicine, Vol. 87, Núm. 4, pp. 234-249

2007

  1. Evaluation of direct E-test on lower respiratory tract samples: a rapid and accurate procedure for antimicrobial susceptibility testing

    Diagnostic Microbiology and Infectious Disease, Vol. 58, Núm. 2, pp. 211-216

1997

  1. Impact of the human immunodeficiency virus epidemic on detection of Mycobacterium isolates in a general hospital

    Journal of Clinical Microbiology, Vol. 35, Núm. 4, pp. 1013-1015

1996

  1. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria

    Journal of Antimicrobial Chemotherapy, Vol. 37, Núm. 1, pp. 151-154

1993

  1. In vitro activity of thalidomide against Mycobacterium avium complex [4]

    Archives of Internal Medicine

  2. Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection

    Archives of Internal Medicine, Vol. 153, Núm. 4, pp. 496-500

  3. Risk for developing tuberculosis among anergic patients infected with HIV

    Annals of Internal Medicine, Vol. 119, Núm. 3, pp. 194-198

1992

  1. Pneumococcal Pneumonia in Adult Hospitalized Patients Infected With the Human Immunodeficiency Virus

    Archives of Internal Medicine, Vol. 152, Núm. 9, pp. 1808-1812

  2. Thalidomide in Patients With Acquired Immunodeficiency Syndrome

    Archives of Internal Medicine

  3. The CLED agar option in urine culture routine. A prospective and comparative evaluation

    Diagnostic Microbiology and Infectious Disease, Vol. 15, Núm. 4, pp. 287-290

  4. Tuberculous meningitis in patients infected with the human immunodeficiency virus

    New England Journal of Medicine, Vol. 326, Núm. 10, pp. 668-672

1990

  1. Nosocomial acinetobacter bacteriemia

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 8, Núm. 10, pp. 606-609